Model Context Protocol3 min read
Qiagen grounds drug discovery agents in curated knowledge
Qiagen N.V. is betting that drug discovery agents need a trustworthy knowledge foundation as much as capable models. For biopharma companies, that means giving agents information with clear provenance and enough context to support their answers.
By Sloane Kali FayeSiliconANGLE

Read the full story
Originally published by SiliconANGLE on Sep 28, 2026.
Comments
Sign in to join the discussion.